Cargando…
Comparative research on (99m)Tc-Rituximab and (99m)Tc-sulfur colloid in sentinel lymph node imaging of breast cancer
BACKGROUND: (99m)Tc-Rituximab is a new specific radiopharmaceutical that binds to the CD20 receptor which is highly expressed on the surface of B cells. We conducted a study in which (99m)Tc-Rituximab was compared with filtered (99m)Tc-sulfur colloid (fTcSC) for sentinel lymph node (SLN) detection i...
Autores principales: | Zhang, Jing-Jie, Zhang, Wan-Chun, An, Cai-Xia, Li, Xiao-Min, Ma, Le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794795/ https://www.ncbi.nlm.nih.gov/pubmed/31615471 http://dx.doi.org/10.1186/s12885-019-6197-9 |
Ejemplares similares
-
Comparison of [(99m)Tc]Tc-tilmanocept with [(99m)Tc]Tc-sulphur colloids and [(99m)Tc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head
por: Ooms, Mark, et al.
Publicado: (2022) -
Cost-Effectiveness of [(99m)Tc]Tilmanocept Relative to [(99m)Tc]Sulfur Colloid for Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer
por: Choi, Karen Y., et al.
Publicado: (2023) -
Sentinel lymph node detection in oral cancer: a within-patient comparison between [(99m)Tc]Tc-tilmanocept and [(99m)Tc]Tc-nanocolloid
por: den Toom, Inne J., et al.
Publicado: (2020) -
Comparison of [(99m)Tc]Tilmanocept and Filtered [(99m)Tc]Sulfur Colloid for Identification of SLNs in Breast Cancer Patients
por: Baker, Jennifer L., et al.
Publicado: (2014) -
The efficacy of (99m)Tc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients
por: Liu, Jiayong, et al.
Publicado: (2022)